Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quest Diagnostics Inc DGX

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer... see more

Recent & Breaking News (NYSE:DGX)

Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD(TM) technology in phase II clinical trial for unresectable stage III NSCLC

PR Newswire January 8, 2024

No-Cost Testing Helps Bolster I-HEAL Community Wellness Day in Mississippi Delta Region

Accesswire January 4, 2024

Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire December 21, 2023

Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer

PR Newswire December 20, 2023

Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis

Accesswire December 19, 2023

Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel

PR Newswire December 19, 2023

Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Seventh Consecutive Year

Accesswire December 18, 2023

Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD(TM) in Clinical Study of Early-Stage Triple-Negative Breast Cancer

PR Newswire December 14, 2023

Quest Diagnostics Multi-Pronged Approach to Waste Reduction

Accesswire December 13, 2023

New Report From Quest Diagnostics Unveils Priorities for Community Health Centers

Accesswire December 11, 2023

Universal DX Announces Strategic Collaboration With Quest Diagnostics To Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

Accesswire December 7, 2023

Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States

PR Newswire December 7, 2023

Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Seventh Consecutive Year

PR Newswire December 6, 2023

ISO Standardization & Climate Action at Quest Diagnostics

Accesswire December 5, 2023

Quest Volunteers Bring Treats, No Tricks, to Ronald McDonald House New York

Accesswire November 28, 2023

Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis

PR Newswire November 28, 2023

Community Engagement at Quest Diagnostics

Accesswire November 27, 2023

Quest Diagnostics Approach to Patient- and Consumer-Centered Care

Accesswire November 21, 2023

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

PR Newswire November 20, 2023

Supply Chain Management at Quest Diagnostics

Accesswire November 15, 2023